Evidence map›Paper›PMID 37061665›Full record

ArticleBMC primary care2023

Use of preventive medication and supplements in general practice in patients in their last year of life: a Retrospective cohort study.

Anne Antonisse, Frederieke H van der Baan, Matthew Grant, Gon Uyttewaal, Cathelijne Verboeket, Hanneke Smits-Pelser, Saskia C C M Teunissen, Eric C T Geijteman

Open access · goldAbstract read
In one paragraph

Article in BMC primary care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

  • Commented on by
    2023
5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anne AntonisseCentre of Expertise Palliative Care, Department General Practice, Julius Centre for Health Sciences and Primary Care, UMC Utrecht, Utrecht, the Netherlands. a.antonisse-2@umcutrecht.nl.
Frederieke H van der BaanCentre of Expertise Palliative Care, Department General Practice, Julius Centre for Health Sciences and Primary Care, UMC Utrecht, Utrecht, the Netherlands.
Matthew GrantCentre of Expertise Palliative Care, Department General Practice, Julius Centre for Health Sciences and Primary Care, UMC Utrecht, Utrecht, the Netherlands.
Gon UyttewaalAcademic Hospice Demeter, de Bilt, the Netherlands.
Cathelijne VerboeketAcademic Hospice Demeter, de Bilt, the Netherlands.
Hanneke Smits-PelserLeidsche Rijn Julius Healthcare Centers, Utrecht, the Netherlands.
Saskia C C M TeunissenCentre of Expertise Palliative Care, Department General Practice, Julius Centre for Health Sciences and Primary Care, UMC Utrecht, Utrecht, the Netherlands.
Eric C T GeijtemanDepartment of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
University Medical Center Utrecht · NLErasmus MC Cancer Institute · NLLeidsche Rijn Julius Health Centers · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral preventive medications and supplements become inappropriate in the last phase of life due to increased risk of adverse events caused by changed pharmacokinetics, drug-drug interactions, and changed care goals. Information on these preventive medication and supplements use in patients with a life-limiting illness in the home-care setting is limited. The primary aim of this study was to assess the use of four different groups of preventive drugs and supplements, which are inappropriate in adult patients with a life-limiting illness, living at home in the last year of life. The secondary aims were to assess reasons for discontinuing these drugs as documented in the general practitioners' patient file and whether these reasons affected the time between medication discontinuation and death.

methodsWe performed a retrospective cohort study using the routine primary care database of the Julius General Practitioners' Network of the University Medical Centre Utrecht, a database consisting of routine care data from GPs from the city of Utrecht and its vicinity. Patients in the homecare setting with a life-limiting illness, diagnosed at least one year before death, were included. Descriptive analyses were used to describe the study population and the frequency of starting, using, and discontinuing medication and supplements in the last year of life.

resultsA total of 458 of 666 included patients (69%) used at least one preventive drug in the last year of life. Vitamins were used by 36% of the patients, followed with 35% using cholesterol-lowering medication, 24% using calcium supplements and 9% using bisphosphonates. Bisphosphonates were discontinued by 70% of the users, calcium supplements by 61%, vitamins by 56% and cholesterol-lowering medication by 48% of the users, with a median interval between day of discontinuation and death of 119, 60, 110 and, 65 days, respectively. The median time between medication or supplement discontinuation and death was longest in patients with side effects and who had medication reviews.

conclusionMany patients in their last phase of life in the home-care setting use inappropriate medication and supplements. Timely medication review may contribute to optimise medication use in the last year of life.

Indexed as

DiphosphonatesFamily PracticeAdultCholesterolHumansRetrospective StudiesVitaminsCholesterolDiphosphonatesVitaminsDiscontinuingHome-care settingInappropriate drugsLife-limiting illnessPalliative carePreventive medication use

Identifiers

PMID37061665
PMCPMC10105458
OpenAlexW4365813978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.